Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen blockade and androgen profile study in healthy women
ACTRN12625001441404Phase 4Not yet recruiting
- Sponsor
- Concord Hospital
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clomiphene and letrozole in reproductive health (SRH) (3 arms), sponsored by Concord Hospital. Primary endpoint: Serum and urine androgen hormone levels. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
clomipheneletrozole
03
Conditions
reproductive health (SRH)
Beyond the preview
Go deeper on ACTRN12625001441404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001441404.